Ticagrelor Tablet
NDC Package 72205-368-91

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Ticagrelor tablets is ticagrelor is used along with low-dose aspirin to help prevent heart attack and stroke in people with heart problems (such as unstable angina, previous heart attack). This formulation utilizes a tablet delivery system. Marketed by Novadoz Pharmaceuticals Llc, this product is identified by NDC 72205-368 and is authorized under FDA application ANDA208596.

Identification & Billing

NDC Package Code
72205-368-91
Package Description
100 TABLET in 1 BOTTLE
Product Code
72205-368
11-Digit Billing Format
72205036891
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Ticagrelor
Non-Proprietary Name
Ticagrelor
Substance Name
Ticagrelor
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
TICAGRELOR 90 mg/1
Pharmacologic Class
Usage Information
Ticagrelor is used along with low-dose aspirin to help prevent heart attack and stroke in people with heart problems (such as unstable angina, previous heart attack). It may also prevent blood clots after certain heart surgeries (such as stent placement). Ticagrelor works by blocking platelets from sticking together and prevents them from forming harmful clots. It is an antiplatelet drug. It keeps blood flowing smoothly in your body.

Regulatory & Marketing

Labeler Name
Novadoz Pharmaceuticals Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA208596
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-07-2020
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (72205-368). Click a package code to view its specific billing and regulatory data.

72205-368-11
10 BLISTER PACK in 1 BOX, UNIT-DOSE / 10 TABLET in 1 BLISTER PACK
72205-368-18
180 TABLET in 1 BOTTLE
72205-368-60
60 TABLET in 1 BOTTLE
72205-368-99
1000 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72205-368-91 identifies a specific commercial package of 100 tablet in 1 bottle of Ticagrelor, a human prescription drug labeled by Novadoz Pharmaceuticals Llc. This tablet is formulated for oral use and contains ticagrelor as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Novadoz Pharmaceuticals Llc on April 07, 2020. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Ticagrelor is used along with low-dose aspirin to help prevent heart attack and stroke in people with heart problems (such as unstable angina, previous heart attack). It may also prevent blood clots after certain heart surgeries (such as stent placement). Ticagrelor works by blocking platelets from sticking together and prevents them from forming harmful clots. It is an antiplatelet drug. It keeps blood flowing smoothly in your body.

How is this Novadoz Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72205036891. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72205-368-91
11-Digit CMS (5-4-2)
72205-0368-91

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.